C015 – Neurobiology of the Visual System

Objectives and lines of research

Objectives

Our group attempts to link basic and clinical science related to Ophthalmology and Visual Sciences in order to develop strategies for early detection of vision-threatening diseases, identification of biomarkers and developing new therapies for ocular diseases, evaluation of pharmacokinetics of intraocular and topical delivered drugs, identification of genetic ocular diseases, and elucidate the mechanisms of visual information processing.

Lines of research

  • Retinal funcion and diseases
  • Orbit and adnexal diseases
  • Ocular Pharmacology

 

Research team

Leader
González García, Francisco

 

Members
Abalo Lojo, José Manuel
Abraldes López-Veiga, Maximino
Conde González, Iria
Iglesias Losada, Ricardo
Oliver Pascual, Nuria

 

External Collaborator Staff
Honkakoski, Paavo
Terasaki, Tetsuya

 
Projects

Publications
  • García-Otero X, Mondelo-García C, Gonzalez F, Perez-Fernandez R, Ávila L, Antúnez-López JR, González-Barcia M, Adan A, Aguiar P, Otero-Espinar FJ, Bermúdez MA, Fernández-Ferreiro A. Anti-inflammatory effect of tacrolimus/hydroxypropyl- -cyclodextrin eye drops in an endotoxin-induced uveitis model. Pharmaceutics, 2021. 13:1737, doi: 10.3390/pharmaceutics13101737.
  • Rodriguez-Ares MT, Touriño R, Lamas-Francis D, Martinez-Perez L, Bustelo M, Gonzalez F. Hand sanitiser-associated ocular chemical injury in children. Journal of Paediatrics and Child Health, 2021. doi: 10.1111/jpc.15395.
  • Garcia-Otero X, Díaz-Tomé V, Varela-Fernández R, Martín-Pastor M, González-Barcia M, Blanco-Méndez J, Mondelo-García C, Bermudez MA, Gonzalez F, Aguiar P, Fernández-Ferreiro A, Otero-Espinar FJ. Development and characterization of a Tacrolimus/Hydroxypropyl–cyclodextrin eye drop. Pharmaceutics, 2021. 13:149. doi: 10.3390/pharmaceutics13020149.
  • Pazo M, Salluce G, Juanes M, Lostale-Seijo I, Garcia-Fandiño R, Gonzalez F, Montenegro J. Short oligoalanine helical peptides for supramolecular nanopore assembly and protein cytosolic delivery. RSC Chemical Biology. 2021, 2:503-512. doi: 10.1039/d0cb00103a
  • Luaces-Rodriguez A, Del Amo EM, Mondelo-Garcia C, Gomez-Lado N, Gonzalez F, Ruibal A, Gonzalez-Barcia M, Zarra-Ferro I, Otero-Espinar FJ, Fernandez-Ferreiro A, Aguiar P. PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats. European Journal of Pharmaceutics and Biopharmaceutics. 2020, 154:330-337. doi: 10.1016/j.ejpb.2020.06.024
  • Abalo-Lojo JM, Pouso-Diz JM, Gonzalez F. Taste and Smell dysfunction in COVID-19 patients. Annals of Otology, Rhinology and Laryngology. 2020. 129:1041-1042. doi: 10.1177/0003489420932617
  • Pouso-Diz JM, Abalo-Lojo JM, Gonzalez F. Thyroid eye disease: current and potential medical management. International Ophthalmology. 2020, 40:1035-1048. doi: 10.1007/s10792-019-01258-7
  • Bermudez MA, Gonzalez F. Differential sensitivity of the On and Off visual responses to retinal ischemia. Experimental Eye Research. 2020; 191:107906. doi: 10.1016/j.exer.2019.107906